| Authors: |
Deutsch JS; Departments of Dermatology, Pathology, and Oncology, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, USA., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital and NSW Health Pathology, The University of Sydney, Sydney, Australia; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Burton E; The University of Texas MD Anderson Cancer Center, Houston, USA., Busam KJ; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Chen KY; Departments of Dermatology, Johns Hopkins University SOM, Baltimore, USA., Cimino-Mathews A; Pathology, Johns Hopkins University SOM, Baltimore, USA., Cottrell TR; Queen's University Sinclair Cancer Research Institute, Kingston, Canada., de Andrea CE; Pathology, University of Navarra, Pamplona, Spain., Fiset PO; Department of Pathology, McGill University Health Centre, Montréal, Canada., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Mater and Royal North Shore Hospitals, Sydney, Australia., Messina J; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA., Rawson RV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital and NSW Health Pathology, The University of Sydney, Sydney, Australia., Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia., Schürch CM; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Seethala RR; University of Pittsburgh Medical Center, Department of Pathology, Pittsburgh, USA., Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, USA., Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, USA., Topalian SL; Department of Surgery, Johns Hopkins University SOM, Baltimore, USA; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, USA; Johns Hopkins Kimmel Cancer Center, Baltimore, USA., van de Wiel BA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Xu X; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Tetzlaff MT; Departments of Pathology and Dermatology, Dermatopathology and Oral Pathology Unit, University of California San Francisco, San Francisco, USA., Taube JM; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University SOM, Baltimore, USA; Departments of Dermatology, Pathology, and Oncology, The Mark Foundation Center for Advanced Imaging and Genomics, Baltimore, USA. Electronic address: jtaube1@jhmi.edu. |
